NCT07544706

Brief Summary

This prospective study aims to evaluate 5-year clinical, radiographic, and patient-reported outcomes of implant-supported crowns and bridges placed on Neoss implants (ProActive Straight and Tapered) in the anterior maxilla (region 13 - 23). The study is conducted at Brånemarkkliniken, Public Dental Service, Västra Götalandsregionen, Sweden. While the treatment involves established methods and CE-marked devices, long-term data for this specific indication are limited.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
51mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Mar 2021Jul 2030

Study Start

First participant enrolled

March 21, 2021

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

April 16, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2030

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2030

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

9 years

First QC Date

April 16, 2026

Last Update Submit

April 16, 2026

Conditions

Keywords

Neoss Dental ImplantsImplant-Supported ProsthesisAnterior MaxillaMarginal Bone LossAesthetic Outcome

Outcome Measures

Primary Outcomes (2)

  • Implant Survival

    Absence of implant loss during the study period.

    Baseline, 1 year, and 5 years

  • Change in marginal bone level around implants

    Change in marginal bone level around implants as assessed by radiographic evaluation using standardized, anonymized radiographs. Measurements will be performed by an independent examiner.

    Baseline, 1 year, and 5 years

Secondary Outcomes (4)

  • Peri-implant Soft Tissue Status and change

    Baseline, 1 year, and 5 years

  • Individual Tooth-Related Pink Esthetic Score (PES)

    Baseline, 1 year, and 5 years

  • Patient-Reported Outcomes

    Baseline, 1 year, and 5 years

  • Incidence of Adverse Events

    Throughout the 5-year study period

Study Arms (1)

Implant-Supported Crowns and Bridges on Neoss Implants (ProActive Straight and Tapered)

EXPERIMENTAL

Participants will receive implant-supported crowns or bridges supported by Neoss implants (ProActive Straight and Tapered) placed in the anterior maxilla as part of routine clinical treatment. Prosthetic rehabilitation will be performed following standard clinical procedures, and participants will be followed for 5 years to assess clinical, radiographic, and patient-reported outcomes.

Device: Neoss Implant System (ProActive Straight and Tapered)

Interventions

Participants will receive implant-supported crowns or bridges supported by Neoss dental implants (ProActive Straight and Tapered) placed in the anterior maxilla. Implant placement and prosthetic rehabilitation will be performed according to standard clinical procedures using a commercially available CE-marked implant system. The implants serve as support for fixed prosthetic restorations, and participants will be followed for 5 years to evaluate clinical, radiographic, and patient-reported outcomes.

Implant-Supported Crowns and Bridges on Neoss Implants (ProActive Straight and Tapered)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent to participate in the study. Adults ≥18 years of age requiring an implant-supported crown or bridge in the anterior maxilla (region 13-23).
  • No prior bone augmentation required at the implant site. The implant site must be free from signs of infection.

You may not qualify if:

  • Individuals under 18 years of age. Individuals unable to provide informed consent due to disease, mental disorder, impaired health status, or similar conditions.
  • Presence of systemic or local disease/condition contraindicating implant treatment.
  • Lack of availability for follow-up visits over the 5-year study period. Previous radiotherapy to the head, neck, or jaw region. Untreated or uncontrolled periodontitis and/or peri-implantitis. Use of immunosuppressive medication. Uncontrolled diabetes mellitus. Severe alcohol and/or substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden

Gothenburg, Sweden

Location

Study Officials

  • Victoria F Stenport, DDS, PhD

    Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden

    PRINCIPAL INVESTIGATOR
  • Jan Kowar, DDS, PhD

    Brånemark Clinic, Public Dental Health Care Service, Region of Västra Götaland, Gothenburg, Sweden

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2026

First Posted

April 22, 2026

Study Start

March 21, 2021

Primary Completion (Estimated)

March 31, 2030

Study Completion (Estimated)

July 31, 2030

Last Updated

April 22, 2026

Record last verified: 2026-04

Locations